You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中牧股份(600195.SH):蘭州生物藥廠通過生物安全三級防護標準驗收
格隆匯 12-02 16:03

格隆匯 12 月 2日丨中牧股份(600195.SH)公佈,公司蘭州生物藥廠(“蘭州廠”)位於蘭州市榆中縣金州路的新廠區(“新廠區”),於近日通過甘肅省畜牧獸醫局獸用疫苗生產企業生物安全三級防護標準的驗收,現將有關情況公告如下:

2018年11月22日,公司第七屆董事會2018年第八次臨時會議審議批准公司投資蘭州廠生產區整體搬遷項目,項目建設內容包括先期建設和餘項建設。截至目前,該項目已累計投入3.9387億元。依據甘肅省畜牧獸醫局現場檢查驗收(生物安全三級防護)的通知書,經專家組綜合評定,蘭州廠新廠區的口蹄疫一車間、質檢室、檢驗動物房的防護區及配套活毒廢水處理設施、污水處理設施、防護措施等符合獸用疫苗生產企業生物安全三級防護標準。

根據《獸藥管理條例》、《獸藥生產質量管理規範(2020年修訂)》和《獸藥產品批准文號管理辦法》等規定,產品在生產、上市銷售前,蘭州廠新廠區還需履行生產線的獸藥GMP驗收和生產線對應產品申請獸藥產品批准文號等程序,公司將按照行業規定履行相應的審批程序,積極推進工作開展。公司蘭州廠生產區整體搬遷至蘭州市高新區榆中園區,是公司落實國家生物安全風險防控要求、改善蘭州廠發展環境和生產條件的重要舉措。此次蘭州廠新廠區通過獸用疫苗生產企業生物安全三級防護標準驗收,有利於進一步提升公司疫苗產品的市場競爭力和盈利水平,滿足市場需求,促進企業可持續發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account